Connect with us

Government

Pearl and Vyne Dental Partner to Streamline Claims Processing

New partnership pairs Pearl’s flagship AI solution, Second Opinion, with Vyne Trellis to elevate smarter, more efficient claims submissions Pearl, the…

Published

on

This article was originally published by AITHORITY
Pearl and Vyne Dental Partner to Streamline Claims Processing

New partnership pairs Pearl’s flagship AI solution, Second Opinion, with Vyne Trellis to elevate smarter, more efficient claims submissions

Pearl, the global leader in dental AI solutions, and Vyne Dental, a leading provider of dental revenue technologies, claims processing, and electronic health information exchange, announced a partnership to pair Pearl’s Second Opinion AI solution with Vyne Trellis, Vyne’s end-to-end revenue acceleration platform. This partnership will provide Trellis users with Pearl’s radiographic image retrieval capabilities, enabling faster, more efficient AI-assisted claims submissions.

AiThority Interview Insights: How to Get Started with Prompt Engineering in Generative AI Projects

“Our partnership with Vyne Dental will enable smarter, more efficient insurance claim filing so that dental professionals can spend less time searching through patient charts for x-rays, and more time on what matters most – delivering quality care to patients.”

“This partnership brings together two of the most innovative technology solutions in dentistry,” said Steve Roberts, president of Vyne Dental. “By joining Pearl’s cutting-edge AI-backed technology with our end-to-end revenue acceleration platform, we are uniquely positioned to revolutionize claims processing, enabling dental practices of all sizes to streamline workflow, enhance efficiency, and ultimately maximize revenue.”

Read More about AiThority InterviewAiThority Interview with Frank Diana, Principal Futurist at Tata Consultancy Services

Vyne Dental processes over 8 million claims per month across more than 50,000 practices, totaling over $4.5 billion in claims monthly. Integrating features from Pearl’s Second Opinion – the first chairside AI software authorized by the FDA to help dentists detect numerous conditions commonly diagnosed in x-rays of adult teeth of patients 12 and older – Vyne Trellis will offer users a more streamlined workflow for sourcing patient x-rays and identifying the most appropriate imagery to support insurance claim submissions. With a few simple clicks, Vyne Trellis users will now be able select and attach patient imagery to claims directly within the application, reducing time spent on compiling and submitting claims by up to 50 percent. As the partnership progresses, the two companies have their sights on developing features aimed to facilitate a revolution in real-time chairside claim adjudication and approvals.

“Pearl’s breakthrough AI technology solutions are designed to enhance efficiency and elevate the standard of care,” said Ophir Tanz, founder and CEO of Pearl. “Our partnership with Vyne Dental will enable smarter, more efficient insurance claim filing so that dental professionals can spend less time searching through patient charts for x-rays, and more time on what matters most – delivering quality care to patients.”

 Latest AiThority Interview Insights : AiThority Interview: Top AI and ML Trends Transforming the Customer Service Industry

 [To share your insights with us, please write to sghosh@martechseries.com] 

The post Pearl and Vyne Dental Partner to Streamline Claims Processing appeared first on AiThority.

Psychedelics

Here Are the Champions! Our Top Performing Stories in 2023

It has been quite a year – not just for the psychedelic industry, but also for humanity as a whole. Volatile might not be the most elegant word for it,…

Continue Reading
Medtech

AI can already diagnose depression better than a doctor and tell you which treatment is best

Artificial intelligence (AI) shows great promise in revolutionizing the diagnosis and treatment of depression, offering more accurate diagnoses and predicting…

Continue Reading
Government

Scientists use organoid model to identify potential new pancreatic cancer treatment

A drug screening system that models cancers using lab-grown tissues called organoids has helped uncover a promising target for future pancreatic cancer…

Continue Reading

Trending